Status:
COMPLETED
Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality
Lead Sponsor:
San Francisco Department of Public Health
Conditions:
Stimulant Overdose
Overdose Accidental
Eligibility:
All Genders
18+ years
Brief Summary
In the LASSO study, the investigators will identify 100 stimulant overdose decedents (divided among stimulant-only, and stimulant with fentanyl), conduct informant interviews (including scales and qua...
Detailed Description
Death from acute stimulant toxicity ("overdose") is rapidly rising across the United States. While there are decades of research and program development undergirding opioid overdose prevention, there ...
Eligibility Criteria
Inclusion
- Inclusion:
- All informants must be at least 18 years of age and have knowledge of the decedent and that the decedent used substances.
- If the contact has knowledge of the decedent's earlier life (e.g., family or long-term friend), the inclusion criteria are that they
- are aware the decedent used substances in the past year prior the to date of death AND
- have been in contact with the decedent in the past year prior to the date of death by phone, email, or in person
- OR
- If the contact has recent knowledge of the decedent (e.g., partners, friends, neighbors, or service providers), the inclusion criteria are that they
- are aware the decedent used substances in the past 30 days prior to the date of death and
- have been in contact with the decedent in person in the past year prior to the date of death.
- Living persons who use stimulants:
- ≥18 years of age,
- Used cocaine or methamphetamine for ≥5 years,
- Used cocaine or methamphetamine for ≥10 out of the past 30 days, AND
- Matched to a decedent on age, race/ethnicity, gender, and neighborhood distribution of decedents of the methamphetamine/no opioid and cocaine/no opioid decedents.
- Exclusion:
- Informants:
- No exclusion criteria.
- Living persons who use stimulants:
- Used both cocaine and methamphetamine ≥5 of past 30 days,
- Intentionally use illicit opioids, OR
- Unable to communicate in English or Spanish.
Exclusion
Key Trial Info
Start Date :
June 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 12 2024
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT06076564
Start Date
June 6 2022
End Date
February 12 2024
Last Update
November 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Department of Public Health
San Francisco, California, United States, 94102